Due to recent changes in the official account push mechanism, we welcome you to set Boom Health as a "starred" account on the homepage of the official account to get the latest trends and expert insights in the digital healthcare industry第一时间!
01 Global Digital Health Investment and Financing OverviewAI-Driven Smart Hospital Platform Artisight Secures $42 Million in Series B FundingOn January 11, Artisight, an AI-driven smart hospital platform, secured $42 million in Series B funding, with investors including NVIDIA. Artisight combines IoT sensors with deep learning and open integration standards to streamline patient care and support remote care, ambient intelligence, and real-time healthcare system applications.Wearable Neurostimulation Therapy Developer Noctrix Health Secures $40 Million in Series C FundingOn January 16, Noctrix Health, a developer of wearable neurostimulation therapies, secured $40 million in Series C funding, led by Sectoral Asset Management. The new round of financing will be used to further advance the marketization of Nidra™ Tonic Motor Activation (TOMAC) therapy.Sleep Diagnostics Device Developer Onera Secures €30 Million in Series C FundingOn January 16, Onera Health, a developer of sleep diagnostic devices, secured €30 million in Series C funding. The round was co-led by new investors EQT Life Sciences, EQT Health Economics 3 fund, and Gimv. The funds will accelerate the company's manufacturing and deployment plans and expedite the approval process for its second-generation polysomnography (PSG) system in Europe and the United States.StairMed, a developer of implantable brain-computer interface technology, announces the completion of its Series A financing round worth hundreds of millions of yuanOn January 15, StairMed, a developer of implantable brain-computer interface technology, announced the completion of its Series A financing round worth hundreds of millions of yuan. The round was jointly led by Orbimed and Yuanhe Origin, with Qifeng Capital serving as the exclusive financial advisor. The funds will be used for system development and team expansion, further solidifying the company’s leading position in the field of implantable brain-computer interfaces.Manteia, a developer of precision radiotherapy software, has completed a 110-million-yuan B-round financing.Recently, Manteia, a precision radiotherapy software developer, completed a 110 million yuan Series B financing round led by the National Ministry of Science and Technology's Achievement Transformation Guidance Fund through Zhongke Haichuang, along with Yangming Capital and industry cooperation institutions. Manteia’s core products include an adaptive radiation therapy (ART) treatment planning system, radiotherapy-related functional systems, data information systems, quality control systems, and real-time analysis and training systems based on deep learning.IVD CDMO Service Provider Colaris Completes Nearly RMB100 Million Series B FinancingRecently, Coloris, an IVD CDMO service provider, has completed a nearly RMB 100 million Series B financing round. This round was led by Luxin Venture Capital, with Hanchi Venture Capital participating. The funds will be used to further accelerate the commercial promotion of a full range of IVD instruments, providing customers in China and internationally with ultra-stable, high-performance, and cost-effective products and CDMO services.Service, becoming a leading independent brand in the in vitro diagnostics equipment industry and a global CDMO supplier.VR Medical Training Solution Provider Oxford Medical Simulation Raises $12.6 Million in Series A FundingOn January 16, VR medical training solutions provider Oxford Medical Simulation secured a $12.6 million Series A funding round, led by Frog Capital. The company plans to use the funds to expand its operations, advance the application of its products in physician training, enhance the integration of artificial intelligence with its solutions, and further support customers in creating their own content.Precision Neurology Software and Data Company Rune Labs Secures $12 Million in Strategic FinancingOn January 11, precision neurology software and data company Rune Labs secured $12 million in strategic funding, led by Nexus NeuroTech Ventures with participation from existing investors. The company focuses on Parkinson's disease, and its developed StrivePD has become the most widely used software by Parkinson's patients and clinicians. It has now established complementary business lines, utilizing its network and data to support clinical development and comprehensive care management.Neurological Disorders Telemedicine Platform Parallel Raises $6.125 Million in Series A FundingOn January 11, Parallel, a teletherapy platform for neurological disorders, secured $6.125 million in Series A funding led by Rethink Impact with participation from insiders. The company plans to use the funds to drive its expansion into new areas and invest in product development. Parallel specializes in virtual neurodevelopmental assessments and support services for conditions such as dyslexia, dysgraphia, dyscalculia, and executive function disorder.Fuhan Medical, a developer of products and services in the field of children's eye health, has completed a multi-million yuan Series A round of financing.On January 12, Fuhhan Medical, a developer of products and services in the field of children's eye health, completed its Series A financing round worth tens of millions of yuan, led by Jinyu Maowu. The funds from this round will aim to accelerate the Kiretem series ultra-wide-field fundus camera in breaking the market monopoly held by international brands, expedite the research, development, and registration of a series of innovative products, and achieve the cross-border export of high-quality Chinese products.ADHD Online Guidance Platform Shimmer Raises $2.2 Million in Seed Funding On January 11, Shimmer, an ADHD online coaching platform, secured $2.2 million in seed funding, led by Worklife Ventures and SeedtoB Capital. The company plans to expand its AI-focused product development and conduct a scientific study on ADHD coaching outcomes under the auspices of top-tier universities in the U.S. and the U.K.Veterinary Care Provider Sploot Veterinary Care Completes Strategic FinancingOn January 16, veterinary care service provider Sploot Veterinary Care completed a strategic investment from L Catterton. Sploot is an innovative, technology-driven, and comprehensive veterinary care platform focused on providing convenient and accessible primary and emergency care. The funding will support Sploot in accelerating the expansion of its differentiated solutions and fulfilling its mission to improve the lives of pets, pet parents, and veterinary professionals.PharmaForce, a pharmacy solutions provider, receives strategic financingOn January 16, pharmacy solutions provider PharmaForce announced that it had received a strategic investment from Aquiline Capital Partners. PharmaForce has delivered transparent and flexible 340B management software to more than 280 customers. Leveraging its partnership with Aquiline, PharmaForce can accelerate strategic mergers and acquisitions and continue to expand its product offerings.Ability.02 Digital Health Industry Dynamics
Isomorphic Labs Partners with Eli Lilly and Novartis RespectivelyOn January 8, Isomorphic Labs announced separate R&D collaborations with Eli Lilly and Company and Novartis to develop small molecule therapies targeting multiple sites using its next-generation AlphaFold technology. The total value of the two collaborations is approximately $3 billion.Bowang Pharmaceutical Licenses Multiple RNAi Therapies to NovartisOn January 7, Argo Biopharma announced that it had entered into two exclusive license cooperation agreements with Novartis regarding RNAi therapy. Argo will receive an upfront payment of $185 million from Novartis and is eligible to receive potential option and milestone payments, as well as tiered royalties on commercial sales. The total potential value of the two deals could reach up to $4.165 billion.03 Global Digital Health M&A OverviewInteger Holdings Corporation Acquires Pulse TechnologiesRecently, Integer Holdings Corporation, a global giant in medical device OEM manufacturing, announced the acquisition of Pulse Technologies, headquartered in Pennsylvania, for $140 million (approximately 1 billion RMB). Integer is a leading global outsourced manufacturer of medical devices, with business covering cardiology, neuromodulation, vascular, portable medical, and orthopedic fields. Pulse, founded in 1993, is a leading precision component manufacturer, specializing in providing services to the medical, industrial, and aerospace/defense sectors.Johnson & Johnson Acquires Ambrx for $2 BillionOn January 9, Johnson & Johnson announced that it had reached a definitive agreement to acquire Ambrx Biopharma, a clinical-stage biopharmaceutical company with a proprietary synthetic biology platform for designing and developing next-generation antibody-drug conjugates (ADCs), in an all-cash merger transaction valuing the total equity at approximately $2 billion, or $1.9 billion after deducting estimated acquired cash.ArteryNet/Arterial Orange Industry Think Tank/China Renaissance/BGI Co-Win/Rock Health/Mobile Health News/Fierce Health, etc.
Compiled by: Zhang Qiankun
